Dynatronics Reports Second Quarter Results
EAGAN, MN / ACCESSWIRE / February 11, 2021 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy,...
Staff
Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial
Cedar Clinical Research to be Evaluated to Support Phase IIb Trial of Novel PTSD Treatment TORONTO, ON / ACCESSWIRE /...
Kadmon Announces Pricing of $200 Million Convertible Senior Notes Offering with 100% Capped Call Transactions
NEW YORK, NY / ACCESSWIRE / February 11, 2021 / Kadmon Holdings, Inc. (Nasdaq:KDMN) today announced the pricing of $200...
Achieve Life Sciences to Present at the MicroCap Rodeo Winter Wonderland Conference on February 16, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / February 11, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed...
Stereotaxis to Present at Upcoming Investor Conferences
ST. LOUIS, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the...
Philips wins ‘Best in KLAS’ award for its Vendor-Agnostic Image Viewer Vue Motion
2021-best-in-klas-universal-viewer-imaging Philips Image Viewer Vue Motion for Clinicìans Philips Vue Motion for Radiologists Philips Vue PACS for 3 screen view...
ATW Tech Concludes an Agreement Regarding the Offering of Its Non-Dominant Canadian Operator Solutions and Its Option.vote Solution With Star Académie Broadcasted on TVA
MONTREAL, Feb. 11, 2021 (GLOBE NEWSWIRE) -- ATW Tech Inc. (the "Company" or “ATW Tech”) (TSX-V: ATW), is proud to...
Delcath Systems to Participate at Upcoming Virtual Investor Conferences
NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment...
Nemaura Medical Secures $20 Million Non-Dilutive Loan to Accelerate Business Growth
Loughborough, England, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology...
Albireo Presents Odevixibat Commercialization Road to $1 Billion
– Company outlining large global rare cholestatic liver disease opportunity – – Advancing plans for anticipated odevixibat U.S. and EU...
Gain Therapeutics Presents Positive Pre-Clinical Data Supportive of In Vitro Target Engagement for Gaucher Disease, GM1 Gangliosidosis and Morquio B Programs at the 17th Annual WORLDSymposium™
STAR candidates for the treatment of Gaucher Disease enhance GCase activity in a neuronal cell model and reduce toxic accumulation...
WW Schedules Fourth Quarter and Full Year 2020 Earnings Conference Call
NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) will release its results for the fourth...
Acer Therapeutics Announces Topline Results from its Bioequivalence Trial of ACER-001 Compared to BUPHENYL® Under Fed Conditions
Targeting a pre-NDA meeting with FDA in Q2 2021NEWTON, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq:...
OrthoPediatrics Corp. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
WARSAW, Ind., Feb. 11, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on...
Outlook Therapeutics Reports Final Visit for Last Patient in Open-Label Safety Study for ONS-5010/LYTENAVA™ (bevacizumab-vikg)
Topline results from open-label safety study (NORSE THREE) on target for Q2 2021MONMOUTH JUNCTION, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE)...
Microbix Reports Results for Q1 Fiscal 2021
Record Q1 Sales, With Nearly 3,600% Year-Over-Year QAPs GrowthMISSISSAUGA, Ontario, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX:...
Biogen Announces the Expiration Date Results of Its Cash Tender Offer
CAMBRIDGE, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced the expiration date results of...
scPharmaceuticals to Present at the 10th Annual SVB Leerink Global Healthcare Conference
BURLINGTON, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing...
Syneos Health Identifies Important Drivers of Change Expected to Disrupt Healthcare
Shared Commitment to Change, New Prescriber Realities, Model Evolution and Engagement Transformation Expected to be Critical DriversMORRISVILLE, N.C., Feb. 11,...
Prothena Reports Fourth Quarter and Full Year 2020 Financial Results, and Provides Financial Guidance and R&D Update
Net cash used in operating and investing activities was $19.1 million in the fourth quarter and $80.6 million for the...